<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Jaundice & Haemorrhagic Disease</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="03-metabolic-and-environmental-issues.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 66.67%;"></div>
                        </div>
                       <span class="progress-text">Lecture 4 of 6</span>
                    </div>
                    <a href="05-injuries-and-infections.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Jaundice & Haemorrhagic Disease</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <section id="jaundice" class="content-section" aria-labelledby="heading-jaundice">
                    <h2 id="heading-jaundice" class="section-heading">
                        <span class="heading-text">NEONATAL JAUNDICE</span>
                    </h2>
                    <div class="content-card">
                        <p>Neonatal Jaundice is a condition in neonates characterised by yellow discolouration of the skin, sclera and mucous membranes. It develops when there is excessive bilirubin levels in the blood stream. When there is increased rate of haemolysis of RBC or decreased conjugation or obstruction of the flow of bile, there will be high amounts of free bilirubin in circulation leading to jaundice.</p>
                        
                        <h3 class="subsection-heading">Bilirubin Metabolism</h3>
                        <p>When aged, immature, malformed RBCs are broken down by hemolysis in the reticuloendothelial system (liver, spleen and the macrophages), they produce haem and globulin. Globulin is stored for reuse. The haeme part is broken down to bilirubin and iron. Iron is stored for re use and uncojugated bilirubin (fat soluble) is waste product which should be excreted. Unconjugated (indirect) bilirubin has to be converted to water soluble form (conjugated/ direct bilirubin) by a process of conjugation for it to be excreted. Conjugation of bilirubin occurs in the liver. If the conjugation process is interfered with, there will be accumulation of unconjugated bilirubin leading to hyperbilirubinaemia and jaundice. This bilirubin may cross the Blood-Brain Barrier and cause brain damage, a condition known as Kernicterus.</p>

                        <h3 class="subsection-heading">Types of jaundice</h3>
                        <p>There are two types of jaundice:</p>
                        <ul>
                            <li>Physiological</li>
                            <li>Pathological</li>
                        </ul>

                        <h4 class="subsubsection-heading">1. PHYSIOLOGICAL JAUNDICE</h4>
                        <p>Physiological jaundice affects both preterm and term babies in the first few days of life. It is a normal occurence but it may indicate a serious condition.</p>
                        <p><strong>Characteristic of physiological jaundice:</strong></p>
                        <ul>
                            <li>Jaundice never appears before 24 hours of age</li>
                            <li>The serum bilirubin levels never exceeds 250 umol/l</li>
                            <li>The highest serum bilirubin level occurs on the 3rd or 4th day of life</li>
                            <li>The jaundice fades by the 7th day of life</li>
                            <li>The baby is otherwise well</li>
                        </ul>
                        <p><strong>Causes of physiological jaundice:</strong> Excessive haemolysis of RBCs, Glucoronyl transferase enzyme deficiency, increased enterohepatic reabsorption, and decreased albumin binding capacity.</p>
                        <p><strong>Nursing management:</strong> Admit to NBU, start early and frequent breast feeding, and monitor serum bilirubin levels. If levels are high, start phototherapy.</p>
                        
                        <h4 class="subsubsection-heading">2. Pathological jaundice</h4>
                        <p>Pathological jaundice appears within 24 hrs of life and is not self-limiting thus may persist for long. There is rapid rise in serum bilirubin. It includes both obstructive and haemolytic jaundice.</p>
                        <p><strong>Causes:</strong> Pathological disorders that increase bilirubin production (e.g., Rhesus and ABO incompatibility, G6PD deficiency), or reduce rate of conjugation or transport.</p>
                        <p><strong>Nursing management:</strong> Assess the baby, investigate serum bilirubin levels, start phototherapy, and order for blood exchange transfusion if necessary.</p>

                        <h3 class="subsection-heading">Complications of neonatal jaundice</h3>
                        <ul>
                            <li>Retinal damage due to light used in treatment</li>
                            <li>Anaemia</li>
                            <li>Hyperthermia associated with phototherapy</li>
                            <li>Hypocalcaemia</li>
                            <li>Kernicterus (characterised by seizures, hyper-tonicity, lethargy, stiff neck)</li>
                        </ul>

                        <h3 class="subsection-heading">Treatment modalities for neonatal jaundice</h3>
                        <p>There are three main modalities:</p>
                        <ol>
                            <li><strong>Phototherapy:</strong> The use of ultraviolet blue light to convert unconjugated bilirubin in the skin to a water-soluble form for excretion.</li>
                            <li><strong>Blood Exchange Transfusion:</strong> The baby's blood is gradually removed and replaced by donor's blood. It is used when bilirubin concentrations are approaching toxic levels.</li>
                            <li><strong>Protoporphyrins:</strong> These are haeme oxygenase inhibitors which are administered to inhibit the breakdown of haeme thus reduce bilirubin production.</li>
                        </ol>
                    </div>
                </section>

                <section id="hdn" class="content-section" aria-labelledby="heading-hdn">
                    <h2 id="heading-hdn" class="section-heading">
                        <span class="heading-text">HAEMORRHAGIC DISEASE OF THE NEW BORN (HDN)</span>
                    </h2>
                    <div class="content-card">
                        <p>This is bleeding that occurs during the first few days of life due to vitamin K deficiency. Vitamin K is synthesised by the bowel normal flora and its role is to convert clotting factors such as prothrombin. To prevent HDN, all neonates are given vitamin K 0.5-1 mg i.m at birth.</p>

                        <h3 class="subsection-heading">Predisposing factors</h3>
                        <ul>
                            <li>Hereditary factors (clotting factor defect)</li>
                            <li>Prematurity</li>
                            <li>Birth trauma</li>
                            <li>Treatment with antibiotics</li>
                            <li>Respiratory distress syndrome</li>
                            <li>Disseminated intravascular coagulopathy (DIC)</li>
                            <li>Birth asphyxia</li>
                            <li>Mothers who are on drugs like warfarin, heparin, phenobarbital</li>
                        </ul>

                        <h3 class="subsection-heading">Clinical features</h3>
                        <ul>
                            <li>Continuous oozing of blood from umbilical cord.</li>
                            <li>There is spontaneous bleeding from various parts of the body.</li>
                            <li>Bleeding in the mucous membranes of GIT and may present with melaena stool or haematemesis.</li>
                            <li>Continuous bleeding from any punctured blood vessel or injection site.</li>
                            <li>Haematuria or omphalorrhagia.</li>
                        </ul>

                        <h3 class="subsection-heading">Nursing Management</h3>
                        <ul>
                            <li>Upon admission into NBU, administer vitamin K 0.5-1 mg I.M.</li>
                            <li>Preserve all linen soiled by blood for estimation of blood loss.</li>
                            <li>Administer vitamin K 1-2 mg to arrest bleeding immediately.</li>
                            <li>Observe vital signs (TPR) every 15 minutes.</li>
                            <li>If bleeding is severe, transfuse fresh blood or frozen plasma at 20 mls/kg of body weight.</li>
                            <li>Observe for signs of shock and if present transfuse with packed cells and fresh whole blood.</li>
                            <li>General management is like any other baby in the unit.</li>
                        </ul>

                        <h3 class="subsection-heading">Complications</h3>
                        <ul>
                            <li>Anaemia</li>
                            <li>Hypovolaemic shock</li>
                            <li>Brain damage</li>
                        </ul>
                    </div>
                </section>

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="03-metabolic-and-environmental-issues.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 66.67%;"></div>
                        </div>
                       <span class="progress-text">Lecture 4 of 6</span>
                    </div>
                    <a href="05-injuries-and-infections.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>